ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 125 filers reported holding ANI PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $1,399,000 | +14.2% | 31,000 | 0.0% | 0.27% | -10.2% |
| Q3 2015 | $1,225,000 | -36.3% | 31,000 | 0.0% | 0.30% | -31.6% |
| Q2 2015 | $1,924,000 | -0.8% | 31,000 | 0.0% | 0.44% | +8.3% |
| Q1 2015 | $1,939,000 | +10.9% | 31,000 | 0.0% | 0.41% | -33.9% |
| Q4 2014 | $1,748,000 | – | 31,000 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
| Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
| Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
| Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
| 1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
| THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
| Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
| Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |